Intuitive Surgical (ISRG) Osake Kurssi
Intuitive Surgical Kurssi
Viimeisten 19 vuoden aikana Intuitive Surgicaln liikevaihto kasvoi 18,9 % vuodessa ja ylsi 10,06 Mrd. USD:een. Osakekohtainen tulos on kasvanut 20,9 % vuodessa viimeisten 19 vuoden aikana. Intuitive Surgicaln nettomarginaali 28,4 % on laskenut verrattuna 29,9 %:iin muutama vuosi sitten. Intuitive Surgicaln 12 kuukauden konsensustavoitehinta on 493,50 USD, noin yli kurssia 17,4 %. 40 analyytikosta 29 suosittaa ostoa — kokonaiskonsensus on Osta.
Intuitive Surgical osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Intuitive Surgical liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Intuitive Surgical -osakkeesta
The business model of Intuitive Surgical Inc. revolves around the development, manufacturing, and marketing of robotic-assisted surgical systems. Intuitive Surgical's flagship product, the da Vinci Surgical System, enables surgeons to perform minimally invasive surgery with enhanced precision, control, and visualization. By combining robotics, software, and surgical expertise, Intuitive Surgical aims to provide innovative solutions that improve patient outcomes, reduce surgical complexity, and enhance the capabilities of healthcare professionals. Intuitive Surgical Inc. continually invests in research and development to expand its product portfolio and remains committed to supporting surgeons and hospitals worldwide in delivering advanced surgical care.
Intuitive Surgical Inc is primarily active in the medical device and healthcare industries.
Intuitive Surgical Inc faces competition from companies such as TransEnterix Inc, Medtronic Plc, and Johnson & Johnson in the market.
Intuitive Surgical Inc is a renowned American company specializing in robotic-assisted surgical systems. Founded in 1995, the company has a rich history of innovation and is widely recognized for its flagship product, the da Vinci Surgical System. This advanced technology revolutionized minimally invasive surgery by providing surgeons with enhanced precision and control. Intuitive Surgical Inc has continuously improved its robotic systems over the years, expanding its applications to various surgical specialties. The company's commitment to research, development, and training has positioned it as a global leader in robotic surgery, benefiting both patients and healthcare professionals worldwide.
Intuitive Surgical Inc has achieved several significant milestones. One notable achievement was the development of the da Vinci Surgical System, a groundbreaking robotic surgical platform that enables surgeons to perform minimally invasive procedures with enhanced precision. The company also introduced the da Vinci Xi System, which offers expanded capabilities and versatility. Moreover, Intuitive Surgical Inc has expanded its global presence by installing over 5,500 da Vinci Systems worldwide. These milestones have solidified Intuitive Surgical Inc's position as a leader in robotic-assisted surgery, providing advanced technology that improves patient outcomes and revolutionizes the healthcare industry.
Intuitive Surgical Inc primarily operates in various countries and regions worldwide. The company has a strong presence in the United States, where it is headquartered. Additionally, Intuitive Surgical Inc has established a significant market presence in Europe, particularly in countries like Germany, France, and the United Kingdom. The company also operates in other parts of the world, including Australia, Japan, China, and South Korea. With its innovative robotic surgical systems and instruments, Intuitive Surgical Inc continues to expand its global footprint, delivering advanced healthcare solutions to patients and healthcare professionals across different regions.
Intuitive Surgical Inc represents values and a corporate philosophy centered around innovation, patient care, and technological advancements in the field of robotic-assisted surgery. As a leading company in the medical industry, Intuitive Surgical Inc is committed to improving surgical outcomes, enabling minimally invasive procedures, and enhancing the overall patient experience. With their flagship product, the da Vinci Surgical System, Intuitive Surgical Inc has revolutionized the way complex surgeries are performed. By combining their cutting-edge technology and a dedication to continuous improvement, Intuitive Surgical Inc strives to provide healthcare professionals with tools that optimize surgical precision, efficiency, and ultimately, patient outcomes.
Analyytikot asettavat tällä hetkellä Intuitive Surgical-osakkeelle keskimääräisen tavoitehinnan 491,15 USD (mediaani: 493,50 USD), mikä merkitsee +16,9 % viimeisimpään hintaan verrattuna. Konsensus perustuu 40 analyytikkoarvioon.
40 analyytikkoa arvioi tällä hetkellä Intuitive Surgical-osaketta: 29 suosittaa ostoa, 10 pitoa ja 1 myyntiä. Vuodelle 2026 analyytikot odottavat Intuitive Surgical-yhtiöltä 11,76 Mrd. USD liikevaihtoa ja 10,65 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Intuitive Surgical-osake noteerataan hintaan 375,87 EUR (420,24 USD).
Intuitive Surgical-osake (ISRG) on listattuna 13 pörssissä, muun muassa: NASDAQ (ISRG), London (0R29.L), SIX (Zürich) (ISRG.SW), XETRA (IUI1.DE), Frankfurt (IUI1.F), München (IUI1.MU), Stuttgart (IUI1.SG), Düsseldorf (IUI1.DU).
Intuitive Surgical Inc. is a leading company specializing in medical technology, focused on the development and manufacture of robotic systems for surgical procedures. The company is headquartered in Sunnyvale, California and was founded in 1995.
odotettu liikevaihto Intuitive Surgical on 11,76 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Intuitive Surgical on 3,84 Mrd. USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Intuitive Surgical:n hinta-voitto-suhde (P/E) on tällä hetkellä 39,47. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Intuitive Surgical-osakkeen arvostusta.
Intuitive Surgical:n hinta-myynti-suhde (P/S) on tällä hetkellä 12,88. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Intuitive Surgical-osakkeen arvostuskennuslukuna.
Intuitive Surgical:n Eulpool-laatuscore on 7/10.
Intuitive Surgical:n ISIN on US46120E6023. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Intuitive Surgical:n WKN on 888024. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Intuitive Surgical:n ticker on ISRG. Tämä pörssinoteeraus käytetään Intuitive Surgical-osakkeiden kauppaan pörssissä.
Intuitive Surgical osake
Intuitive Surgical vertaisryhmä
Intuitive Surgical Ticker
Intuitive Surgical FIGI
Kaikki tunnusluvut ja syvällinen analyysi Intuitive Surgical:sta
Meidän osakeanalyysimme Intuitive Surgical-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Intuitive Surgical:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: